Tag: multiomics global market

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theMultiomics Market?

The increasing need for personalized healthcare is expected to drive the multiomics market. Personalized medicine is becoming more common due to advancements and the demand for targeted therapies. Multiomics provides in-depth individual health profiles for tailored treatment. The Personalized Medicine Coalition reported 16 FDA approvals for personalized therapies in 2023, up from 6 in 2022. Hence, the growth of personalized medicine supports the multiomics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

#What Growth Opportunities Will Drive the Multiomics Market’s CAGR Through 2034?

The multiomics market has experienced rapid growth, increasing from $3.27 billion in 2024 to $3.85 billion in 2025 at a CAGR of 17.9%, due to biomedical research growth, more funding, chronic disease prevalence, technological progress, and better data analysis tools.

The multiomics market is expected to grow to $7.38 billion by 2029, with a CAGR of 17.6%. The growth is driven by AI and machine learning advancements, clinical applications, a growing biopharmaceutical industry, and integrated multiomics platforms. Key trends include technological advancements, new commercial platforms, spatially resolved analysis, and expansion into clinical diagnostics.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theMultiomics Market?

Major companies in the multiomics market are advancing single-cell multiomics platforms to allow high-throughput studies without compromising sample integrity. In February 2023, Becton, Dickinson, and Company, a US-based medical device firm, introduced the BD Rhapsody HT Xpress, enabling isolation and analysis of more cells than earlier models. This system supports simultaneous analysis of multiple cell types, improving research efficiency and insights.

Who Are the Key Market Players Influencing the Growth of the Corn and Multiomics Industry?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Key Market Segments Comprise the Multiomics Market and Drive Its Revenue Growth?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Which Regions Are Emerging as Leaders in the Multiomics Market?

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Multiomics Market 2025, By The Business Research Company:

Multimode-Fiber Cable Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Multiwall Bags Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multiwall-bags-global-market-report

Multifamily Housing Green Buildings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the multiomics market?

The market size of multiomics has seen substantial growth in the recent past. The market is expected to expand from a valuation of $3.27 billion in 2024 to $3.85 billion in 2025, registering a compound annual growth rate (CAGR) of 17.9%. The growth trajectory in the historical period is largely due to factors such as an upsurge in biomedical research, more funding from private and government sectors, higher prevalence of chronic diseases, advancements in technology, and improved computational tools and software for data examination.

What will be the multiomics market size in the future?

The size of the multiomics market is projected to witness a significant spike in the coming years. With a compound annual growth rate (CAGR) of 17.6%, it is expected to reach $7.38 billion in 2029. The anticipated growth during the forecast period can be credited to the advancements made in areas of artificial intelligence and machine learning, the broadening scope of clinical applications, the expanding biopharmaceutical industry, the introduction of collaborative multiomics platforms, and their widening utilization in agriculture and environmental research. Key trends for the forecast period encompass technological progress, the introduction of new multiomics platforms in the commercial market, wider adoption of spatially resolved multiomics analysis, increased usage in biopharmaceutical R&D, and their proliferation into the realm of clinical diagnostics.

Get your multiomics market report here!

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

What main drivers are fueling expansion in the multiomics market?

The growth of the multiomics market is anticipated to surge due to the increasing demand for personalized medicine. Personalized medicine is a medical strategy designed to cater healthcare decisions and treatments to patients individually with consideration to their genetic, environmental, and lifestyle aspects. The surge in personalized medicine is a result of technological advancements, a growing appetite for targeted therapies, and global improvements in healthcare. Multiomics contributes to personalized medicine by giving an in-depth comprehension of someone’s genetic, molecular, and metabolic makeup, thereby empowering healthcare providers to tailor treatments based on the unique characteristics of each patient. For instance, the Personalized Medicine Coalition, a non-profit organization based in the U.S., declared in February 2024 that the FDA had greenlighted 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from 6 in 2022. As such, the growing demand for personalized medicine plays a significant role in boosting the multiomics market.

What key areas define the segmentation of the global multiomics market?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

Who are the dominant players expanding their reach in the multiomics market?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

What key trends are currently impacting the multiomics market’s development?

Dominant businesses in the multiomics sector are innovating by creating advanced single-cell multiomics platforms, providing the scientific community the ability to perform large-scale experiments without compromising on sample integrity. These single-cell multiomics tools amalgamate various omics data and use artificial intelligence to simplify the analysis and understanding of complex biological information, with the help of intricate algorithms and machine learning methodologies. As an example, Becton, Dickinson, and Company, a medical device firm from the US, unveiled the BD Rhapsody HT Xpress in February 2023. This is a high-throughput single-cell multiomics platform designed to allow scientists to isolate, barcode, and analyze individual cells on a larger scale, facilitating analysis of up to eight times more cells in comparison to older models of BD single-cell analyzers. This state-of-the-art BD Rhapsody HT Xpress System ensures zero sample loss and provides flexibility to simultaneously analyze various samples, different cell sizes, and types such as stem cells or cancer cells. This significantly bolsters the capability of researchers to derive more in-depth insights in a shorter span.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

Which regions are emerging as leaders in the multiomics market?

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Multimode-Fiber Cable Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Multiwall Bags Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multiwall-bags-global-market-report

Multifamily Housing Green Buildings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the multiomics market?

The market size of multiomics has seen substantial growth in the recent past. The market is expected to expand from a valuation of $3.27 billion in 2024 to $3.85 billion in 2025, registering a compound annual growth rate (CAGR) of 17.9%. The growth trajectory in the historical period is largely due to factors such as an upsurge in biomedical research, more funding from private and government sectors, higher prevalence of chronic diseases, advancements in technology, and improved computational tools and software for data examination.

What will be the multiomics market size in the future?

The size of the multiomics market is projected to witness a significant spike in the coming years. With a compound annual growth rate (CAGR) of 17.6%, it is expected to reach $7.38 billion in 2029. The anticipated growth during the forecast period can be credited to the advancements made in areas of artificial intelligence and machine learning, the broadening scope of clinical applications, the expanding biopharmaceutical industry, the introduction of collaborative multiomics platforms, and their widening utilization in agriculture and environmental research. Key trends for the forecast period encompass technological progress, the introduction of new multiomics platforms in the commercial market, wider adoption of spatially resolved multiomics analysis, increased usage in biopharmaceutical R&D, and their proliferation into the realm of clinical diagnostics.

Get your multiomics market report here!

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

What main drivers are fueling expansion in the multiomics market?

The growth of the multiomics market is anticipated to surge due to the increasing demand for personalized medicine. Personalized medicine is a medical strategy designed to cater healthcare decisions and treatments to patients individually with consideration to their genetic, environmental, and lifestyle aspects. The surge in personalized medicine is a result of technological advancements, a growing appetite for targeted therapies, and global improvements in healthcare. Multiomics contributes to personalized medicine by giving an in-depth comprehension of someone’s genetic, molecular, and metabolic makeup, thereby empowering healthcare providers to tailor treatments based on the unique characteristics of each patient. For instance, the Personalized Medicine Coalition, a non-profit organization based in the U.S., declared in February 2024 that the FDA had greenlighted 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from 6 in 2022. As such, the growing demand for personalized medicine plays a significant role in boosting the multiomics market.

What key areas define the segmentation of the global multiomics market?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

Who are the dominant players expanding their reach in the multiomics market?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

What key trends are currently impacting the multiomics market’s development?

Dominant businesses in the multiomics sector are innovating by creating advanced single-cell multiomics platforms, providing the scientific community the ability to perform large-scale experiments without compromising on sample integrity. These single-cell multiomics tools amalgamate various omics data and use artificial intelligence to simplify the analysis and understanding of complex biological information, with the help of intricate algorithms and machine learning methodologies. As an example, Becton, Dickinson, and Company, a medical device firm from the US, unveiled the BD Rhapsody HT Xpress in February 2023. This is a high-throughput single-cell multiomics platform designed to allow scientists to isolate, barcode, and analyze individual cells on a larger scale, facilitating analysis of up to eight times more cells in comparison to older models of BD single-cell analyzers. This state-of-the-art BD Rhapsody HT Xpress System ensures zero sample loss and provides flexibility to simultaneously analyze various samples, different cell sizes, and types such as stem cells or cancer cells. This significantly bolsters the capability of researchers to derive more in-depth insights in a shorter span.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

Which regions are emerging as leaders in the multiomics market?

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Multimode-Fiber Cable Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Multiwall Bags Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multiwall-bags-global-market-report

Multifamily Housing Green Buildings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theMultiomics Market?

The increasing need for personalized healthcare is expected to drive the multiomics market. Personalized medicine is becoming more common due to advancements and the demand for targeted therapies. Multiomics provides in-depth individual health profiles for tailored treatment. The Personalized Medicine Coalition reported 16 FDA approvals for personalized therapies in 2023, up from 6 in 2022. Hence, the growth of personalized medicine supports the multiomics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

#What Growth Opportunities Will Drive the Multiomics Market’s CAGR Through 2034?

The multiomics market has experienced rapid growth, increasing from $3.27 billion in 2024 to $3.85 billion in 2025 at a CAGR of 17.9%, due to biomedical research growth, more funding, chronic disease prevalence, technological progress, and better data analysis tools.

The multiomics market is expected to grow to $7.38 billion by 2029, with a CAGR of 17.6%. The growth is driven by AI and machine learning advancements, clinical applications, a growing biopharmaceutical industry, and integrated multiomics platforms. Key trends include technological advancements, new commercial platforms, spatially resolved analysis, and expansion into clinical diagnostics.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theMultiomics Market?

Major companies in the multiomics market are advancing single-cell multiomics platforms to allow high-throughput studies without compromising sample integrity. In February 2023, Becton, Dickinson, and Company, a US-based medical device firm, introduced the BD Rhapsody HT Xpress, enabling isolation and analysis of more cells than earlier models. This system supports simultaneous analysis of multiple cell types, improving research efficiency and insights.

Who Are the Key Market Players Influencing the Growth of the Corn and Multiomics Industry?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Key Market Segments Comprise the Multiomics Market and Drive Its Revenue Growth?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Which Regions Are Emerging as Leaders in the Multiomics Market?

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Multiomics Market 2025, By The Business Research Company:

Multimode-Fiber Cable Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Multiwall Bags Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multiwall-bags-global-market-report

Multifamily Housing Green Buildings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the multiomics market?

The market size of multiomics has seen substantial growth in the recent past. The market is expected to expand from a valuation of $3.27 billion in 2024 to $3.85 billion in 2025, registering a compound annual growth rate (CAGR) of 17.9%. The growth trajectory in the historical period is largely due to factors such as an upsurge in biomedical research, more funding from private and government sectors, higher prevalence of chronic diseases, advancements in technology, and improved computational tools and software for data examination.

What will be the multiomics market size in the future?

The size of the multiomics market is projected to witness a significant spike in the coming years. With a compound annual growth rate (CAGR) of 17.6%, it is expected to reach $7.38 billion in 2029. The anticipated growth during the forecast period can be credited to the advancements made in areas of artificial intelligence and machine learning, the broadening scope of clinical applications, the expanding biopharmaceutical industry, the introduction of collaborative multiomics platforms, and their widening utilization in agriculture and environmental research. Key trends for the forecast period encompass technological progress, the introduction of new multiomics platforms in the commercial market, wider adoption of spatially resolved multiomics analysis, increased usage in biopharmaceutical R&D, and their proliferation into the realm of clinical diagnostics.

Get your multiomics market report here!

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

What main drivers are fueling expansion in the multiomics market?

The growth of the multiomics market is anticipated to surge due to the increasing demand for personalized medicine. Personalized medicine is a medical strategy designed to cater healthcare decisions and treatments to patients individually with consideration to their genetic, environmental, and lifestyle aspects. The surge in personalized medicine is a result of technological advancements, a growing appetite for targeted therapies, and global improvements in healthcare. Multiomics contributes to personalized medicine by giving an in-depth comprehension of someone’s genetic, molecular, and metabolic makeup, thereby empowering healthcare providers to tailor treatments based on the unique characteristics of each patient. For instance, the Personalized Medicine Coalition, a non-profit organization based in the U.S., declared in February 2024 that the FDA had greenlighted 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from 6 in 2022. As such, the growing demand for personalized medicine plays a significant role in boosting the multiomics market.

What key areas define the segmentation of the global multiomics market?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

Who are the dominant players expanding their reach in the multiomics market?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

What key trends are currently impacting the multiomics market’s development?

Dominant businesses in the multiomics sector are innovating by creating advanced single-cell multiomics platforms, providing the scientific community the ability to perform large-scale experiments without compromising on sample integrity. These single-cell multiomics tools amalgamate various omics data and use artificial intelligence to simplify the analysis and understanding of complex biological information, with the help of intricate algorithms and machine learning methodologies. As an example, Becton, Dickinson, and Company, a medical device firm from the US, unveiled the BD Rhapsody HT Xpress in February 2023. This is a high-throughput single-cell multiomics platform designed to allow scientists to isolate, barcode, and analyze individual cells on a larger scale, facilitating analysis of up to eight times more cells in comparison to older models of BD single-cell analyzers. This state-of-the-art BD Rhapsody HT Xpress System ensures zero sample loss and provides flexibility to simultaneously analyze various samples, different cell sizes, and types such as stem cells or cancer cells. This significantly bolsters the capability of researchers to derive more in-depth insights in a shorter span.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

Which regions are emerging as leaders in the multiomics market?

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Multimode-Fiber Cable Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Multiwall Bags Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multiwall-bags-global-market-report

Multifamily Housing Green Buildings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Analyzing the Growth Rate of the Multiomics Market: What’s the Expected CAGR for the Next Decade?

The market size for multiomics has seen a swift escalation in the previous years. The market is forecasted to expand from a value of $3.27 billion in 2024 to $3.85 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 17.9%. This notable growth during the historic timeline is accredited to factors such as intensified biomedical research, boosted government and private investments, a surge in the incidence of chronic diseases, advancements in technology, and the improvement of computational tools and software used in data analysis.

In the coming years, the multiomics market is projected to witness swift expansion. With a compound annual growth rate (CAGR) of 17.6%, it is predicted to reach a value of $7.38 billion by 2029. The escalating growth during the forecast period can be owed to the progress in artificial intelligence and machine learning, widening of clinical applications, burgeoning biopharmaceutical sector, the arrival of cohesive multiomics platforms, and their rising application in environmental and agricultural research. Major trends predicted for the forecast period entail technological leaps, the introduction of the latest commercial multiomics platforms, the application of spatially resolved multiomics examination, its incorporation in biopharmaceutical R&D, and its broadening into clinical diagnostics.

How Are the key drivers expanding the growth of the Multiomics Market?

The multiomics market is predicted to flourish in response to the increasing popularity of personalized medicine. Personalized medicine is a medical model that tailors healthcare choices and treatments to patients on the bases of their genetic make-up, environmental factors, and lifestyle. Factors fueling this trend include progress in technology, a growing need for targeted therapies, and worldwide improvements in healthcare. Multiomics support personalized medicine by offering a comprehensive understanding of a person’s genetic, molecular, and metabolic traits, which allows practitioners to customize treatments to each individual’s unique attributes. For example, the Personalized Medicine Coalition, a non-profit organization in the United States, reported that 16 new personalized therapies for patients with rare diseases were approved by the FDA in 2023, marking significant progress compared to 6 approvals in 2022. Hence, the burgeoning demand for personalized medicine is spurring the growth of the multiomics market.

Request Your Free Multiomics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

What Are the Leading Organizations Impacting the Multiomics Market’s Growth?

Major companies operating in the multiomics market are:

• Bayer AG_x000D_

• Thermo Fisher Scientific Inc._x000D_

• Novartis AG_x000D_

• Becton Dickinson and Company_x000D_

• Eurofins Scientific SE_x000D_

What Are the Most Prominent Trends Driving Change in the Multiomics Market?

Leading firms in the multiomics market are focusing on the development of superior single-cell multiomics platforms. The main aim is to support scientists in conducting large-scale research without compromising the integrity of the samples. Single-cell multiomics platforms combine different omics with the power of artificial intelligence, simplifying the process of complex biological data analysis through the use of advanced algorithms and machine learning technology. An illustration of this is the launch of the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform by Becton, Dickinson, and Company, a medical device company based in the US, in February 2023. This breakthrough system is designed to isolate, barcode, and analyze solitary cells at a higher throughput rate, handling up to eight times more cells than BD’s previous single-cell analyzers. The BD Rhapsody HT Xpress System promises no sample loss, providing the ability to analyze different samples and different cell sizes and types, such as stem or cancer cells, all at once, thus improving researchers’ capacity to gather more information in a shorter span.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

What Major Market Segments Define the Scope and Growth of the Multiomics Market?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

What Regions Are Leading the Charge in the Multiomics Market?

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the Multiomics Market Categorized and Defined in the Industry?

Multiomics refers to the integration and analysis of multiple omics data types, such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics to provide a more comprehensive understanding of biological systems. This technique improves understanding of complex diseases, biomarker identification, and precision medicine.

Browse Through More Similar Reports By The Business Research Company:

Multimode-Fiber Cable Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

Multiwall Bags Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multiwall-bags-global-market-report

Multifamily Housing Green Buildings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: